BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33565520)

  • 1. Transcatheter arterial chemoembolization (TACE) with iRGD peptide in rabbit VX2 liver tumor.
    Liu X; Xie Y; Qi X; Xu K
    J Cancer Res Ther; 2020; 16(7):1703-1709. PubMed ID: 33565520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Infusion of iRGD-Modified ZrO
    Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
    J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
    Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
    Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
    Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
    Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
    Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
    J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
    Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
    J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
    Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
    J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
    Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo-Immuno-Embolization for the Treatment of Hepatocellular Carcinoma.
    Kim H; Choi B; Mouli SK; Choi H; Harris KR; Kulik LM; Lewandowski RJ; Kim DH
    Adv Healthc Mater; 2023 Oct; 12(26):e2300906. PubMed ID: 37163283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
    Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
    J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
    Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
    J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
    Yasui D; Yamane A; Itoh H; Kobayashi M; Kumita SI
    PLoS One; 2020; 15(8):e0222553. PubMed ID: 32756561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.
    Berz AM; Santana JG; Iseke S; Gross M; Pekurovsky V; Laage Gaupp F; Savic LJ; Borde T; Gottwald LA; Boustani AM; Gebauer B; Lin M; Zhang X; Schlachter T; Madoff DC; Chapiro J
    J Vasc Interv Radiol; 2022 Jul; 33(7):764-774.e4. PubMed ID: 35346859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
    Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
    PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor.
    Tang H; Cao C; Zhang G; Sun Z
    Drug Deliv; 2023 Dec; 30(1):1-16. PubMed ID: 36644796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
    Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.